Asher Bio Launches with $55 Million Series A Financing Led by Third Rock Ventures to Discover and Develop Highly Specific Immunotherapies Using a Novel Technology Platform

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/31bJeUz
via IFTTT